Matches in Ubergraph for { <http://purl.obolibrary.org/obo/NCIT_C1431> ?p ?o ?g. }
Showing items 1 to 52 of
52
with 100 items per page.
- NCIT_C1431 IAO_0000115 "A synthetic agent with immune response modifying activity. As an immune response modifier (IRM), imiquimod stimulates cytokine production, especially interferon production, and exhibits antitumor activity, particularly against cutaneous cancers. Imiquimod's proapoptotic activity appears to be related to Bcl-2 overexpression in susceptible tumor cells. (NCI04)" @default.
- NCIT_C1431 NCIT_A32 NCIT_C1909 @default.
- NCIT_C1431 NCIT_NHC0 "C1431" @default.
- NCIT_C1431 NCIT_P106 "Organic Chemical" @default.
- NCIT_C1431 NCIT_P106 "Pharmacologic Substance" @default.
- NCIT_C1431 NCIT_P107 "Imiquimod" @default.
- NCIT_C1431 NCIT_P108 "Imiquimod" @default.
- NCIT_C1431 NCIT_P175 "369100" @default.
- NCIT_C1431 NCIT_P175 "741062" @default.
- NCIT_C1431 NCIT_P207 "C0718327" @default.
- NCIT_C1431 NCIT_P210 "99011-02-6" @default.
- NCIT_C1431 NCIT_P302 "Condyloma; Superficial Basal Cell Carcinoma; Actinic Keratosis" @default.
- NCIT_C1431 NCIT_P319 "P1QW714R7M" @default.
- NCIT_C1431 NCIT_P322 "CTRP" @default.
- NCIT_C1431 NCIT_P322 "FDA" @default.
- NCIT_C1431 NCIT_P322 "GDC" @default.
- NCIT_C1431 NCIT_P325 "A drug used to treat early basal cell skin cancer and certain other skin conditions. It is being studied in the treatment of other types of cancer. Imiquimod is a type of biological response modifier." @default.
- NCIT_C1431 NCIT_P329 "38558" @default.
- NCIT_C1431 NCIT_P330 "38558" @default.
- NCIT_C1431 NCIT_P350 "C14H16N4" @default.
- NCIT_C1431 NCIT_P366 "Imiquimod" @default.
- NCIT_C1431 NCIT_P368 "CHEBI:36704" @default.
- NCIT_C1431 NCIT_P375 "Imiquimod" @default.
- NCIT_C1431 NCIT_P399 "38558" @default.
- NCIT_C1431 normalizedInformationContent "95.413332725061409" @default.
- NCIT_C1431 referenceCount "2" @default.
- NCIT_C1431 hasExactSynonym "1H-Imidazo(4,5-c)quinolin-4-amine, 1-(2-methylpropyl)-" @default.
- NCIT_C1431 hasExactSynonym "4-Amino-1-isobutyl-1H-imidazo(4,5-c)quinoline" @default.
- NCIT_C1431 hasExactSynonym "Aldara" @default.
- NCIT_C1431 hasExactSynonym "IMIQUIMOD" @default.
- NCIT_C1431 hasExactSynonym "Imiquimod" @default.
- NCIT_C1431 hasExactSynonym "R 837" @default.
- NCIT_C1431 hasExactSynonym "S 26308" @default.
- NCIT_C1431 hasExactSynonym "Zyclara" @default.
- NCIT_C1431 hasExactSynonym "imiquimod" @default.
- NCIT_C1431 inSubset NCIT_C116977 @default.
- NCIT_C1431 inSubset NCIT_C116978 @default.
- NCIT_C1431 inSubset NCIT_C128784 @default.
- NCIT_C1431 inSubset NCIT_C157711 @default.
- NCIT_C1431 inSubset NCIT_C157712 @default.
- NCIT_C1431 inSubset NCIT_C176424 @default.
- NCIT_C1431 inSubset NCIT_C177537 @default.
- NCIT_C1431 inSubset NCIT_C63923 @default.
- NCIT_C1431 type Class @default.
- NCIT_C1431 isDefinedBy ncit.owl @default.
- NCIT_C1431 label "Imiquimod" @default.
- NCIT_C1431 subClassOf NCIT_C129820 @default.
- NCIT_C1431 subClassOf NCIT_C1431 @default.
- NCIT_C1431 subClassOf NCIT_C1908 @default.
- NCIT_C1431 subClassOf NCIT_C1909 @default.
- NCIT_C1431 subClassOf NCIT_C274 @default.
- NCIT_C1431 subClassOf NCIT_C308 @default.